The finding that TRAF4 is highly expressed in metastatic PC not only expand the role of the ubiquitination system in human cancers, but also identifies TRAF4 as a new clinical biomarker, predictor of TrkA hyperactivation and PC aggressiveness [78]. This evidence concerns the gene TRAF4 and pachyonychia congenita.